FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Tina-quant Cystatin C Gen.2
K Number: K161817
·
Decision Jul 27, 2016
Classifications
1
FEI Numbers
24
Registration Numbers
24
Same Product Code
21
Applicant Total
14
Review Days
26
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Tina-quant Cystatin C Gen.2
- K Number
- K161817
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 862.1225
- Medical Specialty
- Clinical Chemistry
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Roche Diagnostics Operations (Rdo)
- Date Received
- July 1, 2016
- Decision Date
- July 27, 2016
- Product Code
- NDY
- Advisory Committee
- Clinical Chemistry
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NDY | Test, Cystatin C | FDA class 2 | Clinical Chemistry |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (NDY), ordered by most recent decision date.
Cystatin C
FDA 510(k)
FDA Class 2
·Clinical Chemistry
ADVIA Chemistry Cystatin C_2 Assay (CYSC_2)
FDA 510(k)
FDA Class 2
·Clinical Chemistry
N Latex Cystatin C; N Protein Standard UY
FDA 510(k)
FDA Class 2
·Clinical Chemistry
COBAS C TINA-QUANT CYSTATIN C GEN.2 ASSAY, C.F.A.S. CYSTATIN C CALIBRATOR, CYSTATIN C GEN.2 CONTROL SET
FDA 510(k)
FDA Class 2
·Clinical Chemistry
DIAZYME CYSTATIN C POC TEST KIT
FDA 510(k)
FDA Class 2
·Clinical Chemistry
K-ASSAY CYSTATIN C REAGENT, CALIBRATOR AND CONTROL
FDA 510(k)
FDA Class 2
·Clinical Chemistry
Other Clearances by Roche Diagnostics Operations (Rdo)
| K Number | Device Name | ||
|---|---|---|---|
| K193053 | Tina-quant Hemoglobin A1cDx Gen.3 | Mar 26, 2020 | Substantially Equivalent |
| K192072 | Tina-quant C-Reactive Protein IV | Feb 21, 2020 | Substantially Equivalent |
| K183517 | Ammonia II | Feb 8, 2019 | Substantially Equivalent |
| K182095 | Tina-quant Transferrin ver.2 (urine application) | Nov 5, 2018 | Substantially Equivalent |
| K171080 | ALP IFCC Gen.2 | May 10, 2017 | Substantially Equivalent |
| K160571 | cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay | Dec 19, 2016 | Substantially Equivalent |
| K162593 | HDL-Cholesterol Gen.4 | Oct 19, 2016 | Substantially Equivalent |
| K160570 | Creatine Kinase | May 25, 2016 | Substantially Equivalent |
| K152245 | ONLINE TDM Vancomycin Gen.3 | Jan 8, 2016 | Substantially Equivalent |
| K151578 | Carbamazepine Gen 4 | Oct 22, 2015 | Substantially Equivalent |